UA102139C2 - Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin - Google Patents

Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin

Info

Publication number
UA102139C2
UA102139C2 UAA201110131A UAA201110131A UA102139C2 UA 102139 C2 UA102139 C2 UA 102139C2 UA A201110131 A UAA201110131 A UA A201110131A UA A201110131 A UAA201110131 A UA A201110131A UA 102139 C2 UA102139 C2 UA 102139C2
Authority
UA
Ukraine
Prior art keywords
fullerens
unmodified
treatment
malignant tumors
doxorubicin
Prior art date
Application number
UAA201110131A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Светлана Владимировна Прилуцкая
Original Assignee
Киевский Национальный Университет Имени Тараса Шевченко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Киевский Национальный Университет Имени Тараса Шевченко filed Critical Киевский Национальный Университет Имени Тараса Шевченко
Priority to UAA201110131A priority Critical patent/UA102139C2/en
Publication of UA102139C2 publication Critical patent/UA102139C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for the treatment of malignant tumors with unmodified fullerens Cin combined chemotherapy with anticancer agent doxorubicin, this inhibits the growth of tumor as well as metastases and reduces toxical influence thereof on organism.
UAA201110131A 2011-08-16 2011-08-16 Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin UA102139C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201110131A UA102139C2 (en) 2011-08-16 2011-08-16 Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201110131A UA102139C2 (en) 2011-08-16 2011-08-16 Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin

Publications (1)

Publication Number Publication Date
UA102139C2 true UA102139C2 (en) 2013-06-10

Family

ID=51948977

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201110131A UA102139C2 (en) 2011-08-16 2011-08-16 Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin

Country Status (1)

Country Link
UA (1) UA102139C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11471484B2 (en) 2011-06-30 2022-10-18 Fathi Moussa Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11471484B2 (en) 2011-06-30 2022-10-18 Fathi Moussa Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals

Similar Documents

Publication Publication Date Title
EP4335511A3 (en) Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
WO2014018563A3 (en) Methods for the treatment of cancer
MX2010000465A (en) Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders.
MX2021003858A (en) Conjugates for treating diseases caused by psma expressing cells.
NZ608142A (en) Amatoxin-conjugates with improved linkers
MX343405B (en) Alpha-emitting complexes.
MX343671B (en) Methods of treating bladder cancer.
EP3722810A3 (en) Molecular profiling of tumors
WO2011037643A3 (en) Compositions and methods for detecting and treating prostate carcinoma
MX360404B (en) Compounds for inhibiting cell proliferation in egfr-driven cancers.
MX2013002084A (en) Biomarkers and methods of treatment.
MX344009B (en) Amatoxin-conjugates with improved linkages.
SG10201810928SA (en) Novel antitumoral use of cabazitaxel
MD20160016A2 (en) Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same
MX2013015340A (en) Compositions and methods for the treatment of cancer.
PH12015501088A1 (en) Dimeric compounds
MX2019013776A (en) Treatment of solid tumors using coenzyme q10.
WO2014165782A3 (en) Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety
MX2013002155A (en) Compounds for treatment of cancer.
AU2012240222A8 (en) Methods of treating central nervous system tumors
WO2013081645A3 (en) Erbb3 mutations in cancer
WO2011056566A3 (en) Compounds and methods for treatment of cancer
AU2018244925A1 (en) Compositions for the treatment of drug-resistant tumors and methods of use thereof
WO2012016050A3 (en) Chemoradiotherapy for kras-mutant colorectal cancer
UA102139C2 (en) Method for the treatment of malignant tumors with combination of unmodified fullerens c60 and doxorubicin